Skip to main content
. 2023 Apr 25;9(2):e003029. doi: 10.1136/rmdopen-2023-003029

Figure 3.

Figure 3

Serial changes in the CDAI and clinical remission according to CDAI after discontinuation of tofacitinib or methotrexate in the subgroup. Spaghetti plot (black lines: mean value, grey lines: the values of individual patients) and bar graph of remission rate are shown. (A) RF lower titre group (left) and higher titre group (right) in the tofacitinib discontinuation arm. (B) RF lower titre group (left) and higher titre group (right) in the methotrexate discontinuation arm. Data are mean (SEM) and %. CDAI, Clinical Disease Activity Index; RF, rheumatoid factor.